Journal article
Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.3MB, Terms of use)
-
(Preview, Version of record, pdf, 982.1KB, Terms of use)
-
- Publisher copy:
- 10.1016/S2215-0366(19)30217-2
Authors
- Publisher:
- Elsevier
- Journal:
- Lancet Psychiatry More from this journal
- Volume:
- 6
- Issue:
- 7
- Pages:
- 601-609
- Publication date:
- 2019-06-06
- Acceptance date:
- 2019-05-08
- DOI:
- EISSN:
-
2215-0374
- ISSN:
-
2215-0366
- Keywords:
- Pubs id:
-
pubs:997285
- UUID:
-
uuid:0c26ce89-aea6-49bc-9dc7-db67b9230e31
- Local pid:
-
pubs:997285
- Source identifiers:
-
997285
- Deposit date:
-
2019-05-09
Terms of use
- Copyright holder:
- Furukawa et al
- Copyright date:
- 2019
- Notes:
- © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Supplementary information is available online from Elsevier at: https://doi.org/10.1016/S2215-0366(19)30217-2
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record